First Look at Data on Biosense Webster's Investigational Pulsed Field Ablation Platform Presented at AF Symposium 2023

/PRNewswire/ -- Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech,i announced that positive results...

Related Keywords

Boston ,Massachusetts ,United States ,California ,Irvine ,Viveky Reddy ,Johnson Medtech ,Sarah Wood ,Anthony Hong ,Biosense Webster ,Biosense Webster Inc ,Linkedin ,Twitter ,Johnson Medtech Companies ,Arrhythmia Services ,Neither Biosense Webster Inc ,Data Monitoring Committee ,Prnewswire Biosense Webster Inc ,Exchange Commission ,Clinical Research ,Catheter Program Study Advisory Committee ,Mount Sinai Health System ,Johnson ,International Af Symposium ,Mapping System ,One Year Outcomes ,Annual International ,Cardiac Arrhythmia Services ,Mount Sinai Hospital ,Charitable Trust Professor ,Cardiac Electrophysiology ,Icahn School ,Field Ablation ,Vice President ,Medical Affairs ,Private Securities Litigation Reform Act ,Pulse Field Ablation ,Annual Report ,Note Regarding Forward Looking ,Quarterly Reports ,Neither Biosense Webster ,Johnson Medical ,Program Study Advisory Committee ,Paroxysmal Atrial Fibrillation ,Pulsed Field Ablation ,System With Irreversible Electroporation ,Accessed January ,Relations Contact ,Nc ,